ResMed (RMD) Tops Q3 EPS by 3c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
ResMed (RMD:AU) (RMD) PT Raised to AUD28 at Macquarie
April 27, 2021 3:13 AM EDTMacquarie analyst David Bailey raised the price target on ResMed (RMD:AU) (NYSE: RMD) to AUD28.00 (from AUD27.80) while maintaining a Neutral rating.... More
